Pharmacists Ask FDA For Biosimilar Substitution Power
Three pharmacy trade groups pushed the U.S. Food and Drug Administration to allow pharmacists to substitute biosimilars for their biologic counterparts without physician approval, saying substitution standards don't need another step...To view the full article, register now.
Already a subscriber? Click here to view full article